FTI
64
-5
EA
44
-3
LRCX
64
2
MS
76
2
VTR
69
2
WMT
55
-4
PRGO
43
4
BF.B
39
-3
IP
34
6
ECL
62
5
KMX
38
-9
WM
60
3
SJM
14
2
EOG
37
4
MNST
59
3
THC
48
2
LEN
21
-9
AME
75
3
NDAQ
77
3
GRMN
45
8
FTI
64
-5
EA
44
-3
LRCX
64
2
MS
76
2
VTR
69
2
WMT
55
-4
PRGO
43
4
BF.B
39
-3
IP
34
6
ECL
62
5
KMX
38
-9
WM
60
3
SJM
14
2
EOG
37
4
MNST
59
3
THC
48
2
LEN
21
-9
AME
75
3
NDAQ
77
3
GRMN
45
8
Financhill
Back

Capital Group Dividend Value ETF Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Buy
63

CGDV
Capital Group Dividend Value ETF

Last Price:
$43.97
Seasonality Move:
4.4%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$31.98
Seasonality Move:
-10.99%
Buy
63
Capital Group Dividend Value ETF (CGDV) is a Buy

Is Capital Group Dividend Value ETF a Buy, Sell or Hold?

  • The current Capital Group Dividend Value ETF [CGDV] share price is $43.96. The Score for CGDV is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • CGDV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CGDV Stock Price Chart

What is Capital Group Dividend Value ETF's stock price today?

  • The Capital Group Dividend Value ETF share price today is $43.96
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CGDV is experiencing buying pressure, which is a positive indicator for future bullish movement.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

CGDV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 59.65 Buy
Chaikin Money Flow: 4338721 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.71 - 43.81) Buy
Bollinger Bands (100): (41.28 - 43.16) Buy

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

CGDV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43.49 Buy
20-day SMA: 43.49 Buy
50-day SMA: 42.92 Buy
200-day SMA: 39.68 Buy
8-day EMA: 43.53 Buy
20-day EMA: 43.38 Buy
50-day EMA: 42.94 Buy
200-day EMA: 40.38 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

Capital Group Dividend Value ETF Earnings Growth & CGDV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

Capital Group Dividend Value ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):